Deutsche Bank AG set a GBX 1,610 ($20.90) price target on GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Tuesday, August 8th. The brokerage currently has a neutral rating on the stock.
GSK has been the subject of several other research reports. Beaufort Securities upped their target price on shares of GlaxoSmithKline plc from GBX 1,750 ($22.72) to GBX 2,000 ($25.96) and gave the stock a buy rating in a research report on Thursday, June 1st. Shore Capital restated a hold rating on shares of GlaxoSmithKline plc in a research report on Friday, June 2nd. Liberum Capital reiterated a buy rating and issued a GBX 1,900 ($24.67) price objective on shares of GlaxoSmithKline plc in a report on Tuesday, June 6th. S&P Global set a GBX 1,500 ($19.47) price objective on shares of GlaxoSmithKline plc and gave the company a sell rating in a report on Tuesday, June 6th. Finally, Jefferies Group LLC increased their price objective on shares of GlaxoSmithKline plc from GBX 1,800 ($23.37) to GBX 1,900 ($24.67) and gave the company a buy rating in a report on Friday, June 16th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of Hold and an average price target of GBX 1,724 ($22.38).
GlaxoSmithKline plc (LON GSK) traded down 1.06% on Tuesday, hitting GBX 1490.00. The stock had a trading volume of 7,080,333 shares. GlaxoSmithKline plc has a 52-week low of GBX 1,446.50 and a 52-week high of GBX 1,745.56. The company’s market cap is GBX 72.83 billion. The company has a 50 day moving average price of GBX 1,564.93 and a 200-day moving average price of GBX 1,621.93.
The business also recently announced a dividend, which will be paid on Thursday, October 12th. Shareholders of record on Thursday, August 10th will be paid a GBX 19 ($0.25) dividend. This represents a dividend yield of 1.23%. The ex-dividend date is Thursday, August 10th.
In other GlaxoSmithKline plc news, insider Victoria Whyte sold 4,820 shares of the company’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of GBX 1,693 ($21.98), for a total transaction of £81,602.60 ($105,936.13). Also, insider Manvinder Singh Banga acquired 2,267 shares of GlaxoSmithKline plc stock in a transaction on Wednesday, July 26th. The shares were purchased at an average price of GBX 1,599 ($20.76) per share, for a total transaction of £36,249.33 ($47,058.72). Over the last ninety days, insiders acquired 3,151 shares of company stock valued at $5,054,922.
About GlaxoSmithKline plc
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.